PowderJect signs research deals for needle-less vaccines
This article was originally published in Clinica
Drug delivery company PowderJect has formed research agreements with Zeneca and an unnamed Japanese company to study the delivery of drugs using its needle-less injection system. The UK company's product uses a helium jet to shoot drug particles through the skin and injects powder instead of liquid.
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.